Maternal‐Fetal Interplay During Mid‐gestation: Inflammatory Biomarker Levels in Maternal Sera, Cord Sera and Placenta
American Journal of Reproductive Immunology · 2026-09 · 96 (3)
DOI: 10.1111/aji.70324 ↗Abstract
ABSTRACT Problem Maternal inflammation is linked to adverse maternal and fetal outcomes, but how maternal inflammation affects fetal inflammation during mid‐gestation is not known. Method of Study We measured 20 biomarkers of inflammation, including chemokines, pro‐and anti‐inflammatory cytokines, and immunomodulatory cytokines, in matched maternal and cord sera and placental tissue collected during the second trimester from a diverse cohort ( N = 106). We examined trends in biomarkers across the second trimester using a linear trend test, and compared distributions across sociodemographic groups using a Kruskal‐Wallis test. We calculated Spearman correlation coefficients and stratified the correlation matrices by gestational age at sample collection (
EUVIMED